IPC Signs MoUs with PMBI and NIPER Hajipur to Enhance Drug Quality and Safety
IPC signs MoUs with PMBI and NIPER Hajipur to enhance drug quality, pharmacovigilance, research, safety of biologics and emerging therapies, and patient safety across India, including Jan Aushadhi Kendras.
Drug Quality | 27/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy